Symmetry Medical USA Inc

Form 483 issued June 15, 2016 · Warsaw, Indiana

Inspection
Jun 1 – Jun 15, 2016
Investigator
Debara Reese
Observations
3
Pages
4
FEI number
3004776227

In short: On June 15, 2016, FDA issued a Form 483 with 3 observations to Symmetry Medical USA Inc in Warsaw, Indiana (FEI 3004776227) after an inspection that ran Jun 1 – Jun 15, 2016. The investigator was Debara Reese. Most observations concern cAPA and production & process controls; the most-cited regulation is 21 CFR 820.90 (nonconforming product).

At a glance

CAPA and production & process controls account for 2 of 2 observations.

CAPA1
Production & process controls1

Most cited: 21 CFR 820.90(a) (1×) · 820.75(a) (1×)

What FDA observed

Preview: the opening words of each observation
  1. 01

    Products that do not conform to specifications…

  2. 02

    A process whose results cannot be fully verified by subsequent inspection and test has not been…

1 more observation

Plus the full detail behind each one, exactly as FDA wrote it.

Get the full 483

This inspection in context

Questions about this 483

What did FDA find at Symmetry Medical USA Inc?

FDA listed 3 observations on this Form 483, mostly about cAPA and production & process controls. The most-cited regulation is 21 CFR 820.90 (nonconforming product). The opening words of each observation are shown on this page.

Who inspected Symmetry Medical USA Inc?

Debara Reese is named on this Form 483, for the inspection of Jun 1 – Jun 15, 2016. Each investigator has a profile showing what they cite most.

When was Symmetry Medical USA Inc inspected by FDA?

The inspection ran Jun 1 – Jun 15, 2016, and the Form 483 is dated June 15, 2016.

How do I get the full Form 483 for Symmetry Medical USA Inc?

Download the original PDF from FDA Intel for $99, with no subscription. Your first Form 483 or letter is on us. You also get an invoice PDF with the order.

$99Get it free